BioNTech SE Sponsored ADR (BNTX) vs Incyte Corporation (INCY)
- BioNTech SE Sponsored ADR BNTX 87.57 −2.92%
- Incyte Corporation INCY 112.95 −0.28%
BioNTech SE Sponsored ADR and Incyte Corporation are both Biotechnology companies. BioNTech SE Sponsored ADR and Incyte Corporation are of similar size ($23.0B and $22.7B). BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Incyte Corporation trades at 13.9×. Incyte Corporation grew revenue faster over the last twelve months: 26.9% against −3.33%. Incyte Corporation has the higher net margin (27.7% vs −65.8%) and the higher return on invested capital (60.5% vs −38.4%). Across the 19 metrics below, Incyte Corporation leads on 15 and BioNTech SE Sponsored ADR on 4.
Valuation
Profitability
| Metric | BNTX | INCY | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.24% | 92.62% | 65.16% |
| Operating margin | (77.94%) | 30.56% | 0.00% |
| Net margin | (65.75%) | 27.71% | 0.00% |
| Free cash flow margin | 16.58% | 32.48% | 0.00% |
| Return on equity | (9.53%) | 30.67% | (56.36%) |
| Return on assets | (8.24%) | 23.55% | (48.04%) |
| Return on invested capital | (38.39%) | 60.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack